Efficient hybridoma production using previously frozen splenocytes.

Area of Science:

• Immunology
• Cell Biology
• Biotechnology

Background:

• Hybridoma technology is crucial for monoclonal antibody production.
• Traditionally, fresh splenocytes are used for hybridoma generation.
• Optimizing splenocyte handling can enhance hybridoma production efficiency.

Purpose of the Study:

• To evaluate the feasibility of using cryopreserved splenocytes for hybridoma generation.
• To compare the hybridoma yield from frozen-thawed splenocytes versus fresh splenocytes.
• To identify practical benefits of employing frozen-thawed splenocytes in hybridoma production.

Main Methods:

• Immunizing mice and rats.
• Collecting splenocytes and cryopreserving them.
• Thawing cryopreserved splenocytes.
• Fusing splenocytes with myeloma cells.
• Culturing and selecting hybridoma cell lines.

Main Results:

• Frozen-thawed splenocytes yielded hybridoma cell lines with efficiency comparable to or exceeding that of fresh splenocytes.
• The technique allows for the full utilization of splenocytes from immunized animals.
• Successful generation of monoclonal antibody-secreting hybridomas was achieved.

Conclusions:

• Cryopreservation of splenocytes is a viable method for generating hybridoma cell lines.
• This approach provides enhanced scheduling flexibility and allows for preliminary fusion assessments.
• Utilizing frozen-thawed splenocytes offers practical advantages in monoclonal antibody research.